News
![15/07/2024: Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights in favour of a category of beneficiaries](https://www.affluentmedical.com/wp-content/uploads/2024/07/article_cpimg-1.jpg)
15/07/2024: Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights in favour of a category of beneficiaries
![15/07/2024: Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights in favour of a category of beneficiaries](https://www.affluentmedical.com/wp-content/uploads/2024/07/article_cpimg-1.jpg)
12/07/2024: Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment
![Successful first-in-human implantation of artificial sphincter Artus for the treatment of stress urinary incontinence](https://www.affluentmedical.com/wp-content/uploads/2024/03/actu-1.jpg)
Successful first-in-human implantation of artificial sphincter Artus for the treatment of stress urinary incontinence
![PCR London Valves – Conference, London](https://www.affluentmedical.com/wp-content/uploads/2023/08/PCR-1.jpg)
PCR London Valves – Conference, London
19 -21 November 2023
![LSX Inv€$tival – Conference, London](https://www.affluentmedical.com/wp-content/uploads/2023/08/LSX-1.jpg)
LSX Inv€$tival – Conference, London
13 November 2023
![TCT (Transcatheter Cardiovascular Therapeutics) – Conference, San Francisco – USA](https://www.affluentmedical.com/wp-content/uploads/2023/08/TCT-1.jpg)
TCT (Transcatheter Cardiovascular Therapeutics) – Conference, San Francisco – USA
23 – 26 October 2023